Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care.

Lancet Haematol 2019 03;6(3):e119

The Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia. Electronic address:

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30013-4DOI Listing
March 2019
18 Reads

Publication Analysis

Top Keywords

myc-rearranged diffuse
4
diffuse large
4
b-cell lymphoma
4
large b-cell
4
lymphoma standard
4
therapy myc-rearranged
4
standard care
4
dose-adjusted epoch-r
4
epoch-r therapy
4
standard
1
care
1
lymphoma
1
large
1
therapy
1
myc-rearranged
1
diffuse
1
dose-adjusted
1
b-cell
1

Similar Publications